Loading clinical trials...
Loading clinical trials...
Cancer patients undergoing chemotherapy experience various side effects depending on the treatment protocol used. Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a dose-limiting and quality-of-li...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bilecik Seyh Edebali Universitesi
NCT07352514 · Chemotherapy-induced Peripheral Neuropathy (CIPN), Neuropathic Pain
NCT06994507 · Chemotherapy-induced Peripheral Neuropathy (CIPN)
NCT06858709 · Chemotherapy-induced Peripheral Neuropathy (CIPN), Cancer
NCT06879678 · Chemotherapy-Induced Peripheral Neuropathy (CIPN), Breast Cancer
NCT04739631 · Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Gulhane Education and Research Hospital
Ankara
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions